Phunware Inc (NASDAQ:PHUN) told investors that its Board of Directors has authorized a stock repurchase plan under which the company may buy back up to $5 million of its outstanding common stock.
Russ Buyse, CEO of the enterprise cloud platform for mobile, said in a statement: “We believe repurchasing our common stock is an attractive use of capital, given recent market prices.”
GGX Gold Corp. (TSX-V:GGX) said it has initiated a review of targets at its Gold Drop property in the Greenwood Mining Camp of British Columbia.
The review is focused on tellurium-enriched gold veins. Tellurium is on Canada's list of 31 critical minerals, with applications in solar power and thermoelectric devices.
ARway Corporation (CSE:ARWY) has announced a significant upgrade to its spatial computing Software Developer Kit (SDK) with the release of version 2.0, contributing to the expansion of the company as a major player in the spatial computing and wayfinding market.
The launch of version 2.0 SDK marks the completion of the last major component of the company's AR wayfinding and spatial computing platform. The full ARway platform offering consists of the ARway app - for spatial mapping, The Creator Portal - for content management and analytics , and The ARwayKit SDK - for custom apps and integrations. The ARway SDK is being offered as a SaaS platform or can be used in limited ways for free with the ARway watermark.
Co-Diagnostics Inc (NASDAQ:CODX) will host a booth this week at the 2023 Consumer Electronics Show (CES) this year from January 5-8 in Las Vegas, Nevada. The company will be exhibiting its upcoming Co-Dx PCR at-home and point-of-care platform, currently in the final stages of preparation for clinical evaluations prior to submission to the U.S. Food and Drug Administration for regulatory authorization. Attendees interested in learning more about the company and its products are invited to visit Booth #8063 in the North Hall of the Las Vegas Convention Center.
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced today that the U.S. Food & Drug Administration has granted the company’s Type C meeting request to obtain agreement on the revised protocol endpoints for its Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine, an oral drug with anti-inflammatory and antiviral properties, in patients with mild to moderate COVID-19. The goal date for the FDA to provide its written responses is March 7, 2023.
G2 Energy Corp (CSE:GTOO, OTC:GTGEF) announced that effective January 4, 2023, the management cease trade order issued by the company's principal regulator, the British Columbia Securities Commission on October 31, 2022 under National Policy 12-203 Management Cease Trade Orders has been revoked, as the company has now successfully completed all filings related to its annual and interim financial statements.
AIM ImmunoTech Inc (NYSE:AIM) announced its CEO Thomas Equels will present at the Virtual Investor 2023 Companies to Watch Event on Wednesday, January 18, 2023, at 11:00 AM ET. A live video webcast of the presentation will be available on the Events & Presentations page of the company’s website (aimimmuno.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.
Xigem Technologies (CSE:XIGM, OTCQB:XIGMF) announced that it has granted 1,820,000 incentive stock options under its Stock Option Plan. Each option entitles the holder to purchase one common share of the company at an exercise price of $0.09 for a period of five years from the date of grant and will vest immediately. The options include 490,000 options for officers of the company, 750,000 options for directors of the company, 475,000 options for consultants to the company and 105,000 options for members of the company's Advisory Board. The options were granted on January 5, 2023, by Xigem's board of directors.
Zoglo's Incredible Food Corp. (CSE:ZOG)'s CEO and chief operations officer Jim Delsnyder has resigned, effective December 30, 2022, according to a statement. The plant-based food company will undergo a search for a new chief executive with an emphasis on leading US expansion. Meanwhile, Jordan Ender has been appointed as a director of the company. Ender has more 15 years of experience in the food retail, broker and distribution industry, and he is a VP of Grey Jay Sales & Distribution Ltd. Additionally, Zoglo said it will not proceed with the grant of 4,351,209 stock options, which had been previously announced on December 22.
Xeris Biopharma Holdings (NASDAQ:XERS) announced that CEO Paul Edick will present an overview of the Company at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 pm Pacific Time. To access the presentation, please visit “Events” on the investor relations page of the company’s website at www.xerispharma.com.
Rio2 Limited (TSX-V:RIO, OTCQX:RIOFF) announced that the company has entered into shares for services agreements with certain directors, employees, and consultants whereby they will receive all or a portion of their director fees, wages, or consultancy fees for the period from January 1, 2023 to December 31, 2023 in common shares of the company. The total value of the security based compensation that the company intends to issue is up to $750,000. Alex Black, Klaus Zeitler, Andrew Cox, Ram Ramachandran, Sidney Robinson, Drago Kisic and Albrecht Schneider are currently directors of the company.